Stocks to buy

Compass Pathways (NASDAQ:CMPS) has been beaten up lately. But the fundamentals are rapidly improving, making now a great time to buy this psychedelic stock. Source: Shutterstock CMPS and other companies championing psychedelic-based therapies are seeing legalization tailwinds grow rapidly. Many cities across the U.S. are in talks to decriminalize psilocybin, among other substances. Cities in
0 Comments
Skillz (NYSE:SKLZ) stock has been taking a beating, but underneath the weakness in share price, the operating fundamentals behind SKLZ are improving. More specifically, we’re huge fans of the company’s technological expansion. Source: Gorodenkoff / Shutterstock.com Skillz currently offers a variety of mostly casino-like games like Solitaire, 21 Blitz and pool, as well as some
0 Comments
History has repeatedly shown that market crashes are almost a “natural” part of the investing cycle. On July 19, the S&P 500 saw its worst single-session plunge in months, fueling speculation that a major correction might be around the corner — and that will provide stocks to buy. The spread of the delta variant, which
0 Comments
ContextLogic (NASDAQ:WISH) is well-positioned to benefit from the turbulence that China-based e-commerce companies are facing. Further, after outlining multiple, positive catalysts in my previous column on WISH stock, published on June 28, I have identified several more drivers that are likely to boost the shares over the longer term. Source: sdx15 / Shutterstock.com Among these
0 Comments
Penn National (NASDAQ:PENN) has generated profits in each of the last two quarters — and the company’s first-quarter results were particularly impressive. But that’s not the only reason to like PENN stock. Source: Casimiro PT / Shutterstock.com On top of its quarterly performance, Penn National also looks critically well-positioned to benefit from a meaningful expansion
0 Comments
Biotechnology company Cassava Sciences (NASDAQ:SAVA) has only two primary product candidates, but they’re highly significant. SAVA stock holders, like all biotech-sector investors, should stay informed on all clinical developments as they’re likely to influence the share price. Source: Shutterstock Cassava Sciences shares are particularly sensitive to news-related events. That’s not a bad thing, though, as the
0 Comments
Penn National Gaming (NASDAQ:PENN) produced excellent results for the first quarter, showing that the casino gaming company is now producing free cash flow (FCF). As a result, PENN stock is likely to move significantly higher once the market sees it generate large amounts of cash. Source: Casimiro PT / Shutterstock.com Penn National Gaming has 42
0 Comments
Right now, multiple factors indicate Roku’s (NASDAQ:ROKU) business is growing rapidly. And given the company’s status as a potential takeover target, ROKU stock continues to look very appealing. Source: JHVEPhoto / Shutterstock.com Investors appear to be buying up shares of bigger, more stable tech stocks. The company’s shares have retreated as a result and created
0 Comments